Merz Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.85 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 M
- Revenue Growth 87.34%
- Profit Growth 33.96%
- Ebitda 40.42%
- Net Worth 12.48%
- Total Assets 25.43%
About Merz Bioceuticals
Merz Bioceuticals Private Limited (MBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 May 2010 and has a history of 14 years and nine months. Its registered office is in Panipat, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.85 M.
The company currently has active open charges totaling ₹6.50 M.
Rajesh Kumar and Prem Vati serve as directors at the Company.
Company Details
- Location
Panipat, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100HR2010PTC040528
- Company No.
040528
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Merz Bioceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kumar  | Director | 25-Jun-2011 | Current |
| Prem Vati | Additional Director | 02-May-2017 | Current |
Financial Performance of Merz Bioceuticals.
Merz Bioceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 87.34% increase. The company also saw a substantial improvement in profitability, with a 33.96% increase in profit. The company's net worth Soared by an impressive increase of 12.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merz Bioceuticals?
In 2020, Merz Bioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Index Oil & Chemicals Private LimitedRajesh Kumar is a mutual person
- Winmax Healthcare Private Limited
Rajesh Kumar is a mutual person
- Medwin Impex Private Limited
Rajesh Kumar is a mutual person
Charges (Loans)
₹6.50 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2014 | Punjab National Bank | ₹2.00 M | Open |
| 16 Nov 2012 | Punjab National Bank | ₹4.50 M | Open |
How Many Employees Work at Merz Bioceuticals?
Unlock and access historical data on people associated with Merz Bioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merz Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merz Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
